Avalo Therapeutics, Inc. · NASDAQ:AVTX

Orbimed Advisors LLC's stake in Avalo Therapeutics, Inc. fell to 2.10% (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Orbimed Advisors LLC's stake in Avalo Therapeutics, Inc. fell to 2.10%, 475,165 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
2.10%
Shares
475,165
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
OrbiMed Advisors LLC2.10%475,165

Source

View original at SEC

Related